Amedeo Smart

Free Medical Literature Service

 

Amedeo

Stem Cell Research
  Free Subscription

Articles published in
Nat Med
    September 2024
  1. SAEZ-CIRION A, Mamez AC, Avettand-Fenoel V, Nabergoj M, et al
    Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
    Nat Med. 2024 Sep 2. doi: 10.1038/s41591-024-03277.
    >> Share

    June 2024
  2. CHEN YB, Mohty M, Zeiser R, Teshima T, et al
    Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial.
    Nat Med. 2024 Jun 6. doi: 10.1038/s41591-024-03016.
    >> Share

    May 2024
  3. ZINTER MS, Dvorak CC, Mayday MY, Reyes G, et al
    Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.
    Nat Med. 2024 May 23. doi: 10.1038/s41591-024-02999.
    >> Share

  4. KELLY K, Bloor AJC, Griffin JE, Radia R, et al
    Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease.
    Nat Med. 2024 May 22. doi: 10.1038/s41591-024-02990.
    >> Share

  5. HOUOT R, Bachy E, Cartron G, Gros FX, et al
    Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
    Nat Med. 2024 May 14. doi: 10.1038/s41591-024-03053.
    >> Share

    December 2023
  6. SIRKO S, Schichor C, Della Vecchia P, Metzger F, et al
    Injury-specific factors in the cerebrospinal fluid regulate astrocyte plasticity in the human brain.
    Nat Med. 2023;29:3149-3161.
    >> Share

    November 2023
  7. SPENCER CHAPMAN M, Cull AH, Ciuculescu MF, Esrick EB, et al
    Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease.
    Nat Med. 2023 Nov 16. doi: 10.1038/s41591-023-02636.
    >> Share

    October 2023
  8. RIWES MM, Golob JL, Magenau J, Shan M, et al
    Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation.
    Nat Med. 2023 Oct 19. doi: 10.1038/s41591-023-02587.
    >> Share

  9. HOUOT R, Bachy E, Cartron G, Gros FX, et al
    Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
    Nat Med. 2023 Oct 9. doi: 10.1038/s41591-023-02624.
    >> Share

    September 2023
  10. HOUOT R, Bachy E, Cartron G, Gros FX, et al
    Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial.
    Nat Med. 2023 Sep 14. doi: 10.1038/s41591-023-02572.
    >> Share

    June 2023
  11. BOUZID H, Belk JA, Jan M, Qi Y, et al
    Clonal hematopoiesis is associated with protection from Alzheimer's disease.
    Nat Med. 2023 Jun 15. doi: 10.1038/s41591-023-02397.
    >> Share

    April 2023
  12. CREES ZD, Rettig MP, Jayasinghe RG, Stockerl-Goldstein K, et al
    Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
    Nat Med. 2023;29:869-879.
    >> Share

    March 2023
  13. CARVALHO T
    Stem cell-derived heart cells injected into first patient.
    Nat Med. 2023 Mar 13. doi: 10.1038/d41591-023-00027.
    >> Share

    February 2023

  14. HIV-1 cure after CCR5Delta32/Delta32 allogeneic hematopoietic stem cell transplantation.
    Nat Med. 2023 Feb 27. doi: 10.1038/s41591-023-02215.
    >> Share

  15. JENSEN BO, Knops E, Cords L, Lubke N, et al
    In-depth virological and immunological characterization of HIV-1 cure after CCR5Delta32/Delta32 allogeneic hematopoietic stem cell transplantation.
    Nat Med. 2023 Feb 20. doi: 10.1038/s41591-023-02213.
    >> Share

    January 2023
  16. FOSSATI V, Peruzzotti-Jametti L, Pluchino S
    A neural stem-cell treatment for progressive multiple sclerosis.
    Nat Med. 2023 Jan 13. doi: 10.1038/s41591-022-02164.
    >> Share

  17. GENCHI A, Brambilla E, Sangalli F, Radaelli M, et al
    Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.
    Nat Med. 2023 Jan 9. doi: 10.1038/s41591-022-02097.
    >> Share

    September 2022
  18. IANIRO G, Puncochar M, Karcher N, Porcari S, et al
    Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Nat Med. 2022;28:1913-1923.
    >> Share

  19. OKANO H
    A combined stem-cell-gene therapy strategy for ALS.
    Nat Med. 2022;28:1751-1752.
    >> Share

  20. BALOH RH, Johnson JP, Avalos P, Allred P, et al
    Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial.
    Nat Med. 2022;28:1813-1822.
    >> Share

    July 2022
  21. ROBERTSON NA, Latorre-Crespo E, Terradas-Terradas M, Lemos-Portela J, et al
    Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects.
    Nat Med. 2022;28:1439-1446.
    >> Share

    April 2022
  22. GANAN-GOMEZ I, Yang H, Ma F, Montalban-Bravo G, et al
    Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
    Nat Med. 2022 Apr 28. pii: 10.1038/s41591-022-01827.
    >> Share


  23. A distinct hematopoietic differentiation state characterizes aggressive infant leukemia.
    Nat Med. 2022;28:641-642.
    >> Share

    March 2022
  24. GANAN-GOMEZ I, Yang H, Ma F, Montalban-Bravo G, et al
    Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
    Nat Med. 2022 Mar 3. pii: 10.1038/s41591-022-01696.
    >> Share

    February 2022

  25. Bone marrow transplantation chemotherapy disrupts regenerative brain cell populations.
    Nat Med. 2022 Feb 24. pii: 10.1038/s41591-022-01722.
    >> Share

  26. SAILOR KA, Agoranos G, Lopez-Manzaneda S, Tada S, et al
    Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain.
    Nat Med. 2022 Feb 21. pii: 10.1038/s41591-022-01691.
    >> Share

  27. DU Y, Liang Z, Wang S, Sun D, et al
    Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates.
    Nat Med. 2022 Feb 3. pii: 10.1038/s41591-021-01645.
    >> Share

    November 2021
  28. PHILIPPI A, Heller S, Costa IG, Senee V, et al
    Mutations and variants of ONECUT1 in diabetes.
    Nat Med. 2021;27:1928-1940.
    >> Share

  29. NIROULA A, Sekar A, Murakami MA, Trinder M, et al
    Distinction of lymphoid and myeloid clonal hematopoiesis.
    Nat Med. 2021;27:1921-1927.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016